January 9, 2026
Buying Opportunity
Shares of Beta Bionics are getting crushed today as Bank of America foolishly downgraded the stock to neutral after the company released preliminary 4th quarter results. And just why did they do this? New patient starts came in 4% below analyst’s expectations. Now I could say this is just another example of just how clueless analysts are when it comes to the dynamics of the insulin pump market. But here I will go a step further and state Bank of America is actively helping investors who have shorted the stock.
The good news here is thanks . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
